Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
136 studies found for:    ANGIOTENSIN I-CONVERTING ENZYME
Show Display Options
Rank Status Study
1 Recruiting Blinded Safety & Efficacy Placebo Controlled Study of Icatibant for Angiotensin Converting Enzyme Inhibitor Induced Angioedema
Condition: Angiotensin Converting Enzyme Inhibitor Induced Angioedema
Interventions: Drug: Icatibant;   Drug: Placebo
2 Recruiting ACE-Inhibitor Effects on Total Hip and Knee Arthroplasty Patients
Conditions: Adverse Effects of Angiotensin-converting-enzyme Inhibitors;   Hypotension
Interventions: Drug: Cessation group;   Drug: Continuation group
3 Completed
Has Results
The RAS, Fibrinolysis and Cardiopulmonary Bypass
Conditions: Coronary Artery Disease;   Angiotensin Converting Enzyme;   Angiotensin Receptor Blockers;   Cardiopulmonary Bypass;   Fibrinolysis;   Inflammation
Interventions: Drug: Placebo;   Drug: Ramipril;   Drug: Candesartan
4 Recruiting Dipeptidyl Peptidase-4 Inhibition in Psoriasis Patients With Diabetes (DIP): A Randomized Clinical Trial.
Conditions: Psoriasis;   Type 2 Diabetes Mellitus
Interventions: Drug: Sitagliptin;   Drug: Gliclazide;   Drug: Sitagliptin matched placebo;   Drug: Gliclazide matched placebo capsule
5 Completed Angiotensin Converting Enzyme Inhibitors and Periprocedural Myocardial Infarction
Conditions: Metabolic Syndrome;   Coronary Artery Disease
6 Completed Study of the Interaction Between the Cells Lining Blood Vessels and Angiotensin-Converting Enzyme
Conditions: Atherosclerosis;   Coronary Disease
7 Completed Angiotensin Converting Enzyme Inhibitors & Contrast Induced Nephropathy in Patients Receiving a Cardiac Catheterization
Condition: Kidney Failure
Intervention: Drug: Hold ACEI or ARB
8 Terminated Angiotensin-converting Enzyme Inhibitors and Early Sickle Cell Renal Disease in Children
Condition: Sickle Cell Disease
Interventions: Drug: Enalapril;   Drug: Placebo
9 Terminated Angiotensin-Converting Enzyme Polymorphism and Acute Renal Failure (ECAREA)
Conditions: Kidney Failure, Acute;   Critical Illness
Intervention: Procedure: Blood sampling for PCR
10 Completed ACE Gene Polymorphism and ARDS Outcome
Condition: Adult Respiratory Distress Syndrome
11 Not yet recruiting The Effect of Dipeptidyl Peptidase 4 Inhibition on Growth Hormone Secretion in Women With Polycystic Ovarian Syndrome
Condition: Polycystic Ovary Syndrome
Interventions: Drug: Sitagliptin;   Drug: Placebo
12 Recruiting Outcomes of Angiotensin Converting Enzyme Inhibitor Management Strategies Prior to Coronary Artery Bypass
Condition: Coronary Artery Disease
Interventions: Drug: ACE/ARB continuation;   Drug: ACE/ARB withdrawal
13 Unknown  The Acute Effects of the Angiotensin-Converting Enzyme Inhibitor Enalaprilat on Flow Distribution
Conditions: Hypertension;   Congestive Cardiomyopathy
Intervention: Drug: Enalaprilat
14 Unknown  Evaluation of Ecallantide for the Acute Treatment of Angiotensin Converting Enzyme Inhibitor Induced Angioedema
Condition: Angioedema
Intervention: Drug: ecallantide - Kallikrein inhibitor that blocks the production of bradykinin
15 Unknown  Effectiveness Study on Fosinopril and/or Losartan in Patients With Chronic Kidney Disease Stage 3
Conditions: Chronic Kidney Insufficiency;   Angiotensin-Converting Enzyme Inhibitors;   Angiotensin II Type 1 Receptor Blockers;   Proteinuria
Intervention: Drug: Fosinopril and Losartan
16 Terminated Rhubarb and Angiotensin Converting Enzyme Inhibitor
Condition: Diabetic Kidney Disease
Interventions: Dietary Supplement: rhubarb extract;   Dietary Supplement: placebo
17 Unknown  Dipeptidyl Peptidase-4 Inhibition on Glucagon-like Peptide-1 (GLP-1)
Condition: Glucose Homeostasis
Interventions: Drug: Placebo;   Drug: Januvia
18 Unknown  Chronic Angiotensin Converting Enzyme Inhibitors in Intermediate Risk Surgery
Condition: Hypertension
Interventions: Drug: Take ACE-I;   Drug: Hold ACE-I
19 Completed Angiotensin Converting Enzyme Inhibitors in Marfan Syndrome
Condition: Marfan Syndrome
Intervention: Drug: Coversyl (perindopril)
20 Completed Safety and Tolerability Study of APN01 (Recombinant Human Angiotensin Converting Enzyme 2)
Conditions: Pulmonary Diseases;   Cardiovascular Diseases;   Kidney Diseases;   Cancer Diseases
Interventions: Biological: APN01;   Other: Placebo

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years